For: |
Yi SY, Lee WJ. A |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i40/6536.htm |
Number | Citing Articles |
1 |
Lei Gao, Alexandra Nieters, Hermann Brenner. Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis. European Journal of Human Genetics 2009; 17(12): 1658 doi: 10.1038/ejhg.2009.102
|
2 |
Qi Zhang, Ying‐Yu Ma, Hui‐Ju Wang, Chang‐Ming Shao, Jun Zhang, Zai‐Yuan Ye. Meta‐analysis of the association between P53 codon 72 polymorphisms and gastric cancer. Journal of Surgical Oncology 2013; 107(4): 360 doi: 10.1002/jso.23233
|
3 |
Marc Tänzer, Magdalena Liebl, Michael Quante. Molecular biomarkers in esophageal, gastric, and colorectal adenocarcinoma. Pharmacology & Therapeutics 2013; 140(2): 133 doi: 10.1016/j.pharmthera.2013.06.005
|
4 |
Sneha Mary Alexander, Radhakrishnan Jayalakshmi Retnakumar, Deepak Chouhan, Thillai Natarajan Barani Devi, Sanjai Dharmaseelan, Krishnadas Devadas, Namrata Thapa, Jyoti Prakash Tamang, Sangey Chhophel Lamtha, Santanu Chattopadhyay. Helicobacter pylori in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.713955
|
5 |
Tatsuya Toyama, Zhenhuan Zhang, Mariko Nishio, Maho Hamaguchi, Naoto Kondo, Hirotaka Iwase, Hiroji Iwata, Satoru Takahashi, Hiroko Yamashita, Yoshitaka Fujii. Association of TP53codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients. Breast Cancer Research 2007; 9(3) doi: 10.1186/bcr1682
|
6 |
Hye-Rim Song, Sun-Seog Kweon, Hee Nam Kim, Jin-Mei Piao, Woo-Jun Yun, Jin-Su Choi, Jun-Eul Hwang, Ju-Young Yoon, Hyeong-Rok Kim, Young-Kyu Park, Soo-Hyun Kim, Yoo-Duk Choi, Min-Ho Shin. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. Gastric Cancer 2011; 14(3): 242 doi: 10.1007/s10120-011-0034-4
|
7 |
Joanna Szkandera, Gudrun Absenger, Nadia Dandachi, Peter Regitnig, Sigurd Lax, Michael Stotz, Hellmut Samonigg, Wilfried Renner, Armin Gerger. Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer. Molecular Genetics and Genomics 2012; 287(9): 755 doi: 10.1007/s00438-012-0715-7
|
8 |
Rakhshan Ihsan, Thoudam Regina Devi, Dhirendra Singh Yadav, Ashwani Kumar Mishra, Jagannath Sharma, Eric Zomawia, Yogesh Verma, Rupkumar Phukan, Jagadish Mahanta, Amal Chandra Kataki, Sujala Kapur, Sunita Saxena. Investigation on the Role of p53 Codon 72 Polymorphism and Interactions with Tobacco, Betel Quid, and Alcohol in Susceptibility to Cancers in a High-Risk Population from North East India. DNA and Cell Biology 2011; 30(3): 163 doi: 10.1089/dna.2010.1119
|
9 |
Helena S Thurow, Ricardo Haack, Fernando P Hartwig, Isabel O de Oliveira, Odir A Dellagostin, Denise P Gigante, Bernardo L Horta, Tiago Collares, Fabiana K Seixas. TP53 gene polymorphism: Importance to cancer, ethnicity and birth weight in a Brazilian cohort. Journal of Biosciences 2011; 36(5): 823 doi: 10.1007/s12038-011-9147-5
|
10 |
Bin Xiang, Yuan-Yuan Mi, Teng-Fei Li, Peng-Fei Liu. Updated Meta-analysis of the TP53 Arg72Pro Polymorphism and Gastric Cancer Risk. Asian Pacific Journal of Cancer Prevention 2012; 13(5): 1787 doi: 10.7314/APJCP.2012.13.5.1787
|
11 |
Yukimi Ohmori, Takashi Nomura, Norimasa Fukushima, Fumiaki Takahashi, Takeshi Iwaya, Keisuke Koeda, Satoshi S. Nishizuka. Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms. Journal of Surgical Oncology 2019; 120(7): 1154 doi: 10.1002/jso.25718
|
12 |
Ayse Engin, Bensu Karahalil, Ali Karakaya, Atilla Engin. Association Between XRCC1 ARG399GLN and P53 ARG72PRO Polymorphisms and the Risk of Gastric and Colorectal Cancer in Turkish Population. Archives of Industrial Hygiene and Toxicology 2011; 62(3): 207 doi: 10.2478/10004-1254-62-2011-2098
|
13 |
Lessileia Gomes de Souza, Jacqueline Miranda de Lima, Ismael Dale Cotrim Guerreiro da Silva, Nora Manoukian Forones. P53 Arg72Pro Polymorphism in Gastric Cancer Patients. Journal of Gastrointestinal Cancer 2009; 40(1-2) doi: 10.1007/s12029-009-9078-7
|
14 |
Chen Cheng, Wang Lingyan, Huang Yi, Zhang Cheng, Ye Huadan, Xu Xuting, Xu Leiting, Ye Meng, Duan Shiwei. Association between TLR2, MTR, MTRR, XPC, TP73, TP53 genetic polymorphisms and gastric cancer: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2014; 38(3): 346 doi: 10.1016/j.clinre.2013.12.009
|
15 |
Helena S. Thurow, Fernando P. Hartwig, Clarice S. Alho, Deborah S. B. S. Silva, Rafael Roesler, Ana Lucia Abujamra, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Bernardo L. Horta, Odir A. Dellagostin, Tiago Collares, Fabiana K. Seixas. Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs. Molecular Biology Reports 2013; 40(8): 4929 doi: 10.1007/s11033-013-2593-4
|
16 |
Toru Hiyama, Masaharu Yoshihara, Shinji Tanaka, Kazuaki Chayama. Genetic polymorphisms and esophageal cancer risk. International Journal of Cancer 2007; 121(8): 1643 doi: 10.1002/ijc.23044
|
17 |
Yang Zhang, Erich M. Sturgis, Zhigang Huang, Mark E. Zafereo, Qingyi Wei, Guojun Li. Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck. Cancer 2012; 118(2): 485 doi: 10.1002/cncr.26222
|
18 |
Han-chun Chen, Hui-juan Chen, Md. Asaduzzaman Khan, Zhou-zhou Rao, Xin-xing Wan, Bo Tan, Dian-zheng Zhang. Genetic mutations of p53 and k-ras in gastric carcinoma patients from Hunan, China. Tumor Biology 2011; 32(2): 367 doi: 10.1007/s13277-010-0129-2
|
19 |
Marilanda Ferreira Bellini, Aline Cristina Targa Cadamuro, Maysa Succi, Marcela Alcântara Proença, Ana Elizabete Silva. Alterations of theTP53Gene in Gastric and Esophageal Carcinogenesis. Journal of Biomedicine and Biotechnology 2012; 2012: 1 doi: 10.1155/2012/891961
|
20 |
Yong Zhou, Ni Li, Wen Zhuang, Guan‐Jian Liu, Tai‐Xiang Wu, Xun Yao, Liang Du, Mao‐Ling Wei, Xiao‐Ting Wu. P53 codon 72 polymorphism and gastric cancer: A meta‐analysis of the literature. International Journal of Cancer 2007; 121(7): 1481 doi: 10.1002/ijc.22833
|
21 |
Yong Zhou, Ni Li, Wen Zhuang, Xiaoting Wu. p53 Codon 72 Polymorphism and Gastric Cancer Risk in a Chinese Han Population. Genetic Testing and Molecular Biomarkers 2010; 14(6): 829 doi: 10.1089/gtmb.2010.0115
|
22 |
Xiu-Li Su, Jian-Jun Jin. Pro Variant of TP53 Arg72Pro Contributes to Gastric Cancer Risk in Asians: Evidence from a Meta-analysis. Asian Pacific Journal of Cancer Prevention 2012; 13(3): 915 doi: 10.7314/APJCP.2012.13.3.915
|
23 |
Liu Liu, Kai Wang, Zheng-Ming Zhu, Jiang-Hua Shao. Associations Between P53 Arg72Pro and Development of Digestive Tract Cancers: A Meta-analysis. Archives of Medical Research 2011; 42(1): 60 doi: 10.1016/j.arcmed.2011.01.008
|
24 |
Kui-Jie Liu, Hai-Zhi Qi, Hong-Liang Yao, San-Lin Lei, Zhen-Dong Lei, Tie-Gang Li, Hua Zhao. An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk. Molecular Biology Reports 2012; 39(8): 8265 doi: 10.1007/s11033-012-1674-0
|
25 |
Wenru Tang, Xuhong Zhou, Shengjie Nie, Zhi Yang, Hui Zhu, Xiaoming Wu, Ruoping Zhao, Ying Luo. Association of p53 Arg72Pro polymorphism with gastric cancer: a meta-analysis. Biomarkers 2012; 17(7): 597 doi: 10.3109/1354750X.2012.704646
|
26 |
Morteza Ghojazadeh, Mohammad Hossein Somi, Amirreza Naseri, Hanieh Salehi-Pourmehr, Sina Hassannezhad, Arash Hajikamanaj Olia, Leila Kafshdouz, Zeinab Nikniaz. Systematic Review and Meta-analysis of TP53, HER2/ERBB2, KRAS, APC, and PIK3CA Genes Expression Pattern in Gastric Cancer. Middle East Journal of Digestive Diseases 2022; 14(3): 335 doi: 10.34172/mejdd.2022.292
|
27 |
Fanglin Li, Erich M. Sturgis, Xingming Chen, Mark E. Zafereo, Qingyi Wei, Guojun Li. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer 2010; 116(10): 2350 doi: 10.1002/cncr.25072
|
28 |
Zhao-Hui Huang, Dong Hua, Li-Hua Li, Jing-De Zhu. Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy. Journal of Cancer Research and Clinical Oncology 2008; 134(10): 1129 doi: 10.1007/s00432-008-0380-8
|
29 |
Maria Juliana D. Teixeira, Ana Paula V. Sobral, Maria do Carmo Abreu-e-Lima, Frederico C.L. Maia, Madriano Christilis, Daniela M.B. Souza, Manoel Adrião, Aurea Wischral. Avaliação da superexpressão da proteína p53 e das mutações no éxon 8 do gene TP53 em carcinomas mamários caninos e glândulas normais. Pesquisa Veterinária Brasileira 2011; 31(6): 521 doi: 10.1590/S0100-736X2011000600011
|
30 |
Anna D. Panani. Cytogenetic and molecular aspects of gastric cancer: Clinical implications. Cancer Letters 2008; 266(2): 99 doi: 10.1016/j.canlet.2008.02.053
|
31 |
Young-Jae Hwang, Nayoung Kim, Chang Yong Yun, Min Gu Kwon, Sung Min Baek, Yeong Jae Kwon, Hye Seung Lee, Jae Bong Lee, Yoon Jin Choi, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee. Predictive Factors for Improvement of Atrophic Gastritis and Intestinal Metaplasia: A Long-term Prospective Clinical Study. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(3): 186 doi: 10.7704/kjhugr.2018.18.3.186
|